Houstek J, Klement P, Floryk D, Antonická H, Hermanská J, Kalous M, Hansíková H, Hout'ková H, Chowdhury S K, Rosipal T, Kmoch S, Stratilová L, Zeman J
Department of Bioenergetics, Institute of Physiology, Academy of Sciences of the Czech Republic, Vídenská 1083, CZ 142 20 Prague 4, Czech Republic,
Hum Mol Genet. 1999 Oct;8(11):1967-74. doi: 10.1093/hmg/8.11.1967.
We report a new type of fatal mitochondrial disorder caused by selective deficiency of mitochondrial ATP synthase (ATPase). A hypotrophic newborn from a consanguineous marriage presented severe lactic acidosis, cardiomegaly and hepatomegaly and died from heart failure after 2 days. The activity of oligomycin-sensitive ATPase was only 31-34% of the control, both in muscle and heart, but the activities of cytochrome c oxidase, citrate synthase and pyruvate dehydrogenase were normal. Electrophoretic and western blot analysis revealed selective reduction of ATPase complex but normal levels of the respiratory chain complexes I, III and IV. The same selective deficiency of ATPase was found in cultured skin fibroblasts which showed similar decreases in ATPase content, ATPase hydrolytic activity and level of substrate-dependent ATP synthesis (20-25, 18 and 29-33% of the control, respectively). Pulse-chase labelling of patient fibroblasts revealed low incorporation of [(35)S]methionine into assembled ATPase complexes, but increased incorporation into immunoprecipitated ATPase subunit beta, which had a very short half-life. In contrast, no difference was found in the size and subunit composition of the assembled and newly produced ATPase complex. Transmitochondrial cybrids prepared from enucleated fibroblasts of the patient and rho degrees cells derived from 143B. TK(-)human osteosarcoma cells fully restored the ATPase activity, ATP synthesis and ATPase content, when compared with control cybrids. Likewise, the pattern of [(35)S]methionine labelling of ATPase was found to be normal in patient cybrids. We conclude that the generalized deficiency of mitochondrial ATPase described is of nuclear origin and is caused by altered biosynthesis of the enzyme.
我们报告了一种由线粒体ATP合酶(ATPase)选择性缺乏引起的新型致命线粒体疾病。一名来自近亲婚姻的发育不全新生儿出现严重乳酸酸中毒、心脏肥大和肝脏肿大,并在2天后死于心力衰竭。在肌肉和心脏中,寡霉素敏感的ATPase活性仅为对照的31%-34%,但细胞色素c氧化酶、柠檬酸合酶和丙酮酸脱氢酶的活性正常。电泳和蛋白质印迹分析显示ATPase复合物选择性减少,但呼吸链复合物I、III和IV的水平正常。在培养的皮肤成纤维细胞中发现了相同的ATPase选择性缺乏,其ATPase含量、ATPase水解活性和底物依赖性ATP合成水平也有类似下降(分别为对照的20%-25%、18%和29%-33%)。对患者成纤维细胞进行脉冲追踪标记发现,[(35)S]甲硫氨酸掺入组装好的ATPase复合物的量较低,但掺入免疫沉淀的ATPase亚基β的量增加,且该亚基半衰期很短。相比之下,组装好的和新产生的ATPase复合物在大小和亚基组成上没有差异。与对照胞质杂种相比,由患者去核成纤维细胞和源自143B.TK(-)人骨肉瘤细胞的rho0细胞制备的线粒体胞质杂种完全恢复了ATPase活性、ATP合成和ATPase含量。同样,在患者胞质杂种中发现ATPase的[(35)S]甲硫氨酸标记模式正常。我们得出结论,所描述的线粒体ATPase普遍缺乏是核源性的,由该酶生物合成改变引起。